Pay in 4 interest-free payments of $143.12 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
In cellular mechanistic assays
PubMed PMID: 25550133
It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53
InChiKey: IBPVXAOOVUAOKJ-UHFFFAOYSA-N
BCX 4430 Size:Solid 10 mg In cellular mechanistic assaysGalidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,